Donation
Donate
Cell-based tumor immunotherapies
We are improving cancer treatment in children and adults with cell-based immunotherapies.
Goal (Phase 1 - Introduction of CAR-T cell therapy manufacturing): €1.000.000
Payed: €199.860,12